Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1998-12-11
pubmed:abstractText
An epidemiological survey on human calicivirus (HuCV) infections and associated gastroenteritis in infants was conducted to clarify the prevalence of HuCV infections in infants and adults in Kenya. Enzyme immunoassays (EIAs) for three genogroups of HuCVs, Norwalk virus (NV), Mexico virus (MXV), and Sapporo virus (SV), were used to detect antigen or antibody. We tested 1,431 stool samples obtained from children younger than 6 years old with acute gastroenteritis who visited outpatient clinics in three districts in Kenya from August 1991 to July 1994. Thirty-two (2.2%) of these stool samples were positive for SV antigen. Only one (0.1%) of 1,186 samples was positive for NV antigen and none of 246 samples was positive for MXV antigen. One hundred ninety-three serum samples were tested for antibodies to NV and MXV, and 64 of them were examined for antibody to SV. The pattern of the age-related prevalence of serum antibody to NV was different from that of antibodies to MXV and SV. The acquisition of serum antibodies to HuCVs in the three genogroups appeared in early childhood, at about 1 to 2 years of age. The prevalence of serum antibody to NV was low (about 60%) throughout adulthood compared with a high prevalence of antibody (approximately 80 to 90%) to MXV and SV. These data indicate that infections with viruses in the three genogroups of HuCVs are common in Kenya, and immunological responses to NV may be different from those to MXV and SV. The EIAs for the detection of NV and MXV antigens appear to be quite specific for prototype NV and MXV strains, respectively, so that they can detect only a few strains of HuCVs related to them. Alternatively, NV and MXV caused less severe infections that did not bring children to the outpatient clinics for gastroenteritis in Kenya.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-1313095, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-1328679, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-1383265, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-2066587, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-2822762, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-2993353, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-3001130, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-3182991, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-6092424, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-7561789, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-7595381, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-7650166, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-7699028, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-8014518, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-8126165, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-8158109, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-8195618, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-8386099, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-8551259, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-8620912, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-8796425, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-8801289, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-8920827, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-9267456, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-9672617, http://linkedlifedata.com/resource/pubmed/commentcorrection/9774557-9705378
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0095-1137
pubmed:author
pubmed:issnType
Print
pubmed:volume
36
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3160-3
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Prevalence of human calicivirus infections in Kenya as determined by enzyme immunoassays for three genogroups of the virus.
pubmed:affiliation
Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo, Japan. snakata@sapmed.ac.jp
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't